VAERS 1314436
PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN620A
- Staat
- RI
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 15.05.2021
- Impfdatum
- 11.03.2021
- Beginn
- 01.04.2021
- Tage bis Beginn
- 21,0
- Dosis
- 2
- Route/Site
- - / LA
Symptomtext
diagnosed with a pulmonary embolism; dry cough; This is a spontaneous report received from a contactable consumer (patient). A 75-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 11Mar2021 10:45 (Lot number: EN620A) as 2nd dose, single (at age of 75-year-old) for covid-19 immunization. Medical history included diabetes mellitus and cholesterol. Concomitant medications in two weeks prior to the vaccination included acetylsalicylic acid (ASPIRIN 81), cyanocobalamin (VITAMIN B-12) and metformin. First vaccine dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), was administered on 18Feb2021 in Left arm (at age of 75-year-old) for COVID-19 immunization, lot number: EL9262. Patient did not receive other vaccine in four weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. It was reported that on 11Mar2021 patient received his second (2nd) shot. Late in Mar2021 or early Apr2021 he developed a dry cough and on 21Apr2021 was diagnosed with a pulmonary embolism. Events resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Onset date of the events was reported as 01Apr2021. Event pulmonary embolism required admission to hospital for one day (dates unknown) event also considered serious as life-threatening. Patient was treated for the events with blood thinner infusion with (w/) Eliquis follow up. It was reported that since the vaccination, the patient has been tested for COVID-19. As of 10May2021, it was reported that the patient had a blood clot in his lung; he has pulmonary embolism in his left lung. The patient had the last shot on 11Mar2021 and he started experiencing a clot two weeks after that and then, he was not diagnosed with the blood clot in 21Apr2021 he believed; he was experiencing coughing system two or three weeks before when he was actually diagnosed with the blood clot. The patient has been treated for blood clot for long, he doesn't know what is that, he was on Eliquis (treatment for blood clot) to break up the clot or still in his blood or whatever the process is, it takes like three months. When he was hospitalized for this, he had been on Heparin trip for about 12 hours heparin blood DNA they had been intravenous. The patient underwent laboratory tests and procedures which included sars-cov-2 test: negative on 21Apr2021. Patient was recovering from the events. Information on the lot/batch number has been requested. Follow-up (10May2021): New information reported from a contactable consumer includes: medical history, concomitant medication and clinical course details.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 1,0
- Labordaten
- Test Date: 20210421; Test Name: Nasal Swab; Test Result: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Cholesterol (Verbatim: Cholesterol); Diabetes (Verbatim: Diabetes)
- Andere Medikamente
- ASPIRIN 81; VITAMIN B-12; METFORMIN
- Allergien
- -
- Vorherige Impfungen
- -